These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism. Prandoni P J Support Oncol; 2006 Mar; 4(3):127-8. PubMed ID: 16553138 [No Abstract] [Full Text] [Related]
31. Low-molecular-weight heparins in the management of cardiovascular conditions. Kayser SR Prog Cardiovasc Nurs; 1998; 13(1):34-40. PubMed ID: 9614687 [No Abstract] [Full Text] [Related]
32. Low molecular weight heparins in cardiovascular medicine. De Lorenzo F; Dotsenko O; Kakkar VV Minerva Cardioangiol; 2005 Dec; 53(6):585-603. PubMed ID: 16333240 [TBL] [Abstract][Full Text] [Related]
33. Treatment of deep vein thrombosis using low-molecular-weight heparins. Groce JB Am J Manag Care; 2001 Nov; 7(17 Suppl):S510-5; discussion S515-23. PubMed ID: 11732662 [TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Mismetti P; Laporte S; Darmon JY; Buchmüller A; Decousus H Br J Surg; 2001 Jul; 88(7):913-30. PubMed ID: 11442521 [TBL] [Abstract][Full Text] [Related]
35. Low-molecular-weight heparin and survival in patients with malignant disease. Kakkar AK Cancer Control; 2005 Sep; 12 Suppl 1():22-30. PubMed ID: 16179901 [No Abstract] [Full Text] [Related]
36. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread. Hettiarachchi RJ; Smorenburg SM; Ginsberg J; Levine M; Prins MH; Büller HR Thromb Haemost; 1999 Aug; 82(2):947-52. PubMed ID: 10605808 [No Abstract] [Full Text] [Related]
37. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes. Nguyen-Ho P; Levine GN Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429 [TBL] [Abstract][Full Text] [Related]
38. Low-molecular-weight heparin for initial treatment of venous thromboembolism. Brewer D Am Fam Physician; 2005 Jul; 72(1):75-6. PubMed ID: 16035683 [No Abstract] [Full Text] [Related]
39. Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke. Padma V; Fisher M; Moonis M Expert Rev Cardiovasc Ther; 2006 May; 4(3):405-15. PubMed ID: 16716101 [TBL] [Abstract][Full Text] [Related]
40. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Mismetti P; Laporte-Simitsidis S; Tardy B; Cucherat M; Buchmüller A; Juillard-Delsart D; Decousus H Thromb Haemost; 2000 Jan; 83(1):14-9. PubMed ID: 10669147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]